Showing 1 - 10 results of 10 for search 'Curtis L. Cooper', query time: 0.01s Refine Results
  1. 1
    Viral Response to Specifically Targeted Antiviral Therapy for Hepatitis C and the Implications for Treatment Success

    Viral Response to Specifically Targeted Antiviral Therapy for Hepatitis C and the Implications for Treatment Success by Curtis L Cooper

    Published 2010-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Fasciitis Complicating Subcutaneous Injection of Interferon Beta

    Fasciitis Complicating Subcutaneous Injection of Interferon Beta by Curtis L Cooper, Rachel Gerstein, Kelly Kaita

    Published 2000-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C Virus

    Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepati... by Cecilia T Costiniuk, Edward Mills, Curtis L Cooper

    Published 2008-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Characteristics of Hepatitis C Virus Infection in HIV-Infected People

    Characteristics of Hepatitis C Virus Infection in HIV-Infected People by Curtis L Cooper, Andrew D Badley, Jonathan B Angel

    Published 2001-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Parasitic Disease Screening among HIV Patients from Endemic Countries in a Toronto Clinic

    Parasitic Disease Screening among HIV Patients from Endemic Countries in a Toronto Clinic by Cecilia T Costiniuk, Curtis L Cooper, Steve Doucette, Colin M Kovacs

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity

    Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity by Mathieu D’Souza, Alexa Keeshan, Christopher A. Gravel, Marc-André Langlois, Curtis L. Cooper

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Barriers Preventing Liver Transplantation in Canadians with HIV Infection – Perceptions of HIV Specialists

    Barriers Preventing Liver Transplantation in Canadians with HIV Infection – Perceptions of HIV Specialists by Curtis L Cooper, Joanne DeForest, John Gill, Richard Lalonde, on behalf of the Canadian HIV Trials Network (CTN) Co-Infection Core Group

    Published 2007-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians

    Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians by Curtis L Cooper, Robert J Bailey, Vince G Bain, Frank Anderson, Eric M Yoshida, Mel Krajden, Paul Marotta, for the Canadian Pegasys Study Group

    Published 2008-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity

    Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, toleranc... by Jonathan B Angel, Ashok Kumar, Michaeline McGuinty, Curtis L Cooper, Juthaporn Cowan, Paul A MacPherson, Sanjay Murthy, Richmond Sy, Michelle Dennehy, Nancy Tremblay, Siddappa N Byrareddy, D William Cameron

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy

    Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based... by Eric M Yoshida, Morris Sherman, Vincent G Bain, Curtis L Cooper, Marc Deschênes, Paul J Marotta, Samuel S Lee, Mel Krajden, Helga Witt-Sullivan, Robert J Bailey, Christopher Usaty, Kevork Peltekian, the Canadian Pegasys Study Group

    Published 2009-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: